secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001628280-25-021506
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics appoints Neil Gallagher and Stuart Duty to Board of Directors
--------------------------------------------------------------------------------

- Stuart Duty and Neil Gallagher appointed effective May 1, 2025 as Class II directors.
- Each granted initial option to purchase 50,000 shares vesting over three years.
- Duty to serve on Audit Committee; Gallagher on Science Committee.
- Duty receives annual cash retainers $40,000 board + $7,500 audit; Gallagher $40,000 + $5,000 science.
- Audit Committee now has three independent members, regaining Nasdaq compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025021506/0001628280-25-021506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025021506/fhtx-20250425.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-021506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer